FDA Approves Pirtobrutinib for R/R Mantle Cell Lymphoma
The US Food and Drug Administration (FDA) has granted accelerated approval to pirtobrutinib (Jaypirca) for relapsed or refractory mantle cell ...
The US Food and Drug Administration (FDA) has granted accelerated approval to pirtobrutinib (Jaypirca) for relapsed or refractory mantle cell ...
The US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) in the adjuvant setting for patients with stage IB-IIIA non–small ...
A man in his 40s is encouraging people to get tested after he was diagnosed with stage 4 colon cancer, ...
The study covered in this summary was published on Preprints With The Lancet as a preprint that has not yet ...
Roflumilast cream 0.3% is under review by the Food and Drug Administration for the treatment of plaque psoriasis in children ...
© 2022 Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical News Hubb All rights reserved.